{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:48:23Z","timestamp":1790894903751,"version":"4.1.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Excessive polypharmacy, which can be defined as the concurrent use of \u226510 medications, is prevalent among individuals with chronic pain. However, it remains unclear how it may vary between individuals or over time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aimed to describe and identify factors associated with trajectories of excessive polypharmacy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective longitudinal study was conducted using the TorSaDE Cohort, which links Canadian Community Health Surveys (2007\u20132016) and Quebec health administrative databases. Among 9,156 adults living with chronic pain and covered by public prescribed drug insurance, the presence of excessive polypharmacy (yes\/no) was assessed monthly for one-year post-survey completion (12 time points). Group-based trajectory modelling was applied to identify groups with similar patterns over time (trajectories). Multivariable multinomial regression was used to identify factors associated with trajectory membership.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Four trajectories were obtained: (1) \u201cNo excessive polypharmacy\u201d (74.8%); (2) \u201cSometimes in excessive polypharmacy\u201d (8.6%); (3) \u201cOften in excessive polypharmacy\u201d (6.1%); 4) \u201cAlways in excessive polypharmacy\u201d (10.5%). Factors associated with the \u201calways in excessive polypharmacy\u201d trajectory membership were: being older, being born in Canada, having a lower income, having a higher comorbidity index score, more severe pain intensity, and more daily activities prevented by pain, reporting arthritis or back pain and poorer perceived general health, and having a family physician. Using opioids or benzodiazepines, having a lower alcohol consumption, doing less physical activity, a higher number of prescribers and visits to a family physician also predicted being always in excessive polypharmacy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study identifies distinct trajectories of excessive polypharmacy in adults with chronic pain, emphasizing key sociodemographic and clinical factors and the need for tailored interventions for effective medication management.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpain.2025.1512878","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:39:18Z","timestamp":1740119958000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Unpacking excessive polypharmacy patterns among individuals living with chronic pain in Quebec: a longitudinal study"],"prefix":"10.3389","volume":"6","author":[{"given":"Gwenaelle","family":"De Clifford-Faug\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermine Lore","family":"Nguena Nguefack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Beaudoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Gabrielle","family":"Pag\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Gu\u00e9nette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumar Mall\u00e9","family":"Samb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Lacasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the iasp classification of chronic pain for the international classification of diseases (Icd-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"key":"B2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Andrew","year":"2014","journal-title":"Pain Pract"},{"key":"B3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2165\/11630040-000000000-00000","article-title":"Barriers to pain management: focus on opioid therapy","volume":"32","author":"Zuccaro","year":"2012","journal-title":"Clin Drug Investig"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1503\/cmaj.111065","article-title":"Better management of chronic pain care for all","volume":"183","author":"MacDonald","year":"2011","journal-title":"CMAJ"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1016\/j.pain.2012.09.001","article-title":"The power of longitudinal population-based studies for investigating the etiology of chronic widespread pain","volume":"153","author":"Kingma","year":"2012","journal-title":"Pain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/703947","article-title":"The pain crisis: what it is and what can be done","volume":"2012","author":"Sessle","year":"2012","journal-title":"Pain Res Treat"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1185\/03007995.2015.1072088","article-title":"A holistic approach to chronic pain management that involves all stakeholders: change is needed","volume":"31","author":"Kress","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"B8","volume-title":"Chronic Pain in Canada: Laying a Foundation for Action","author":"Campbell","year":"2019"},{"key":"B9","volume-title":"Working Together to Better Understand, Prevent and, Manage Chronic Pain: What We Heard","author":"Campbell","year":"2020"},{"key":"B10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/jech.53.8.503","article-title":"Impact of chronic pain on health care seeking, self care, and medication. Results from a population-based Swedish study","volume":"53","author":"Andersson","year":"1999","journal-title":"J Epidemiol Community Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.pain.2010.12.036","article-title":"A population-based survey of chronic pain and its treatment with prescription drugs","volume":"152","author":"Toblin","year":"2011","journal-title":"Pain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s12630-010-9305-5","article-title":"The Canadian stop-pain project\u2013part 1: who are the patients on the waitlists of multidisciplinary pain treatment facilities?","volume":"57","author":"Choini\u00e8re","year":"2010","journal-title":"Can J Anaesth"},{"key":"B13","doi-asserted-by":"publisher","first-page":"830153","DOI":"10.3389\/fpain.2022.830153","article-title":"Gender differences in medication adverse effects experienced by people living with chronic pain","volume":"3","author":"Nguefack HL","year":"2022","journal-title":"Front Pain Res"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.23970\/AHRQEPCCER229","volume-title":"Opioid Treatments for Chronic Pain","author":"Chou","year":"2020"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.23970\/AHRQEPCCER228","volume-title":"Nonopioid Pharmacologic Treatments for Chronic Pain","author":"McDonagh","year":"2020"},{"key":"B16","doi-asserted-by":"publisher","first-page":"26335565211005870","DOI":"10.1177\/26335565211005870","article-title":"Prevalence of chronic pain in ltcs and multimorbidity: a cross-sectional study using UK biobank","volume":"11","author":"McQueenie","year":"2021","journal-title":"J Multimorb Comorb"},{"key":"B17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40263-018-0522-8","article-title":"Polypharmacy among headache patients: a cross-sectional study","volume":"32","author":"Ferrari","year":"2018","journal-title":"CNS Drugs"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.2147\/JPR.S411451","article-title":"Polypharmacy and excessive polypharmacy among persons living with chronic pain: a cross-sectional study on the prevalence and associated factors","volume":"16","author":"Zahlan","year":"2023","journal-title":"J Pain Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/pme.12586","article-title":"Polypharmacy and chronic pain: harm exposure is not all about the opioids","volume":"16","author":"Giummarra","year":"2015","journal-title":"Pain Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4212\/cjhp.v66i3.1261","article-title":"Deprescribing: what is it and what does the evidence tell US?","volume":"66","author":"Thompson","year":"2013","journal-title":"Can J Hosp Pharm"},{"key":"B21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","article-title":"Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences","volume":"12","author":"Pazan","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"B23","volume-title":"Medication Safety in Polypharmacy","year":"2019"},{"key":"B24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2165\/00002512-200926060-00006","article-title":"Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the kuopio 75+ study: a cross-sectional analysis","volume":"26","author":"Jyrkka","year":"2009","journal-title":"Drugs Aging"},{"key":"B25","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/gerona\/glr233","article-title":"Polypharmacy in nursing home in Europe: results from the shelter study","volume":"67","author":"Onder","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1111\/jocn.14371","article-title":"Prevalence and factors associated with polypharmacy in the older people: 2006\u20132014","volume":"27","author":"Carmona-Torres","year":"2018","journal-title":"J Clin Nurs"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","article-title":"Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study","volume":"10","author":"Chang","year":"2020","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00228-007-0422-1","article-title":"The clinical implications of ageing for rational drug therapy","volume":"64","author":"Shi","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.26355\/eurrev_202101_24673","article-title":"Prescribing cascades and medications most frequently involved in pain therapy: a review","volume":"25","author":"Nunnari","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.japh.2017.06.002","article-title":"Association between polypharmacy and death: a systematic review and meta-analysis","volume":"57","author":"Leelakanok","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40266-023-01028-2","article-title":"Classifying polypharmacy according to pharmacotherapeutic and clinical risks in older adults: a latent class analysis in Quebec, Canada","volume":"40","author":"Gosselin","year":"2023","journal-title":"Drugs Aging"},{"key":"B32","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/jppr.1749","article-title":"Association between polypharmacy and depression: a systematic review and meta-analysis","volume":"51","author":"Palapinyo","year":"2021","journal-title":"J Pharm Pract Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11606-019-04837-7","article-title":"Associations between polypharmacy, symptom burden, and quality of life in patients with advanced, life-limiting illness","volume":"34","author":"Schenker","year":"2019","journal-title":"J Gen Intern Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1176\/appi.ps.52.8.1033","article-title":"Psychopharmacology: rational and irrational polypharmacy","volume":"52","author":"Kingsbury","year":"2001","journal-title":"Psychiatr Serv"},{"key":"B35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1056\/NEJMp1713159","article-title":"Controlling the swing of the opioid Pendulum","volume":"378","author":"Comerci G","year":"2018","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40545-018-0154-x","article-title":"Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare","volume":"11","author":"Brandt","year":"2018","journal-title":"J Pharm Policy Pract"},{"key":"B37","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1186\/s12877-023-04441-9","article-title":"Prescribing differences among older adults with differing health cover and socioeconomic Status: a cohort study","volume":"23","author":"Prendergast","year":"2023","journal-title":"BMC Geriatr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2147\/CLEP.S265287","article-title":"Trajectory modelling techniques useful to epidemiological research: a comparative narrative review of approaches","volume":"12","author":"Nguena Nguefack","year":"2020","journal-title":"Clin Epidemiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1038\/s41598-021-86331-x","article-title":"A multidimensional measure of polypharmacy for older adults using the health and retirement study","volume":"11","author":"Carr","year":"2021","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1066-h","DOI":"10.1093\/ije\/dyaa167","article-title":"Cohort profile: the care trajectories\u2014enriched data (torsade) cohort","volume":"50","author":"Vanasse","year":"2021","journal-title":"Int J Epidemiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/pm\/pnaa004","article-title":"Validity of algorithms for identification of individuals suffering from chronic noncancer pain in administrative databases: a systematic review","volume":"21","author":"Lacasse","year":"2020","journal-title":"Pain Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/pds.3820","article-title":"Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?","volume":"24","author":"Lacasse","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B43","volume-title":"Canadian Community Health Survey\u2014annual Component (Cchs)\u2014detailed Information for 2012","year":"2012"},{"key":"B44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/BF03404102","article-title":"How reliable are selected scales from population-based health surveys? An analysis among seniors","volume":"90","author":"Raina","year":"1999","journal-title":"Can J Public Health"},{"key":"B45","first-page":"10","article-title":"Linking the Canadian community health survey and the Canadian mortality database: an enhanced data source for the study of mortality","volume":"27","author":"Sanmartin","year":"2016","journal-title":"Health Rep"},{"key":"B46","article-title":"La R\u00e9gie De L'assurance Maladie Du Qu\u00e9bec Qu\u00e9bec: Gouvernement du Qu\u00e9bec","year":"2017"},{"key":"B47","article-title":"Rapport Annuel De Gestion 2017\u20132018 Qu\u00e9bec, Qc: R\u00e9gie de l'assurance maladie du Qu\u00e9bec, Gouvernement du Qu\u00e9bec","year":"2018"},{"key":"B48","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0895-4356(94)00234-H","article-title":"The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec","volume":"48","author":"Tamblyn","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"key":"B50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1155\/2007\/762180","article-title":"Chronic pain in Canada: have we improved our management of chronic noncancer pain?","volume":"12","author":"Boulanger","year":"2007","journal-title":"Pain Res Manag"},{"key":"B51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1155\/2002\/323085","article-title":"Chronic pain in Canada\u2013prevalence, treatment, impact and the role of opioid analgesia","volume":"7","author":"Moulin","year":"2002","journal-title":"Pain Res Manag"},{"key":"B52","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1155\/2012\/875924","article-title":"The epidemiology of chronic pain in Canadian men and women between 1994 and 2007: longitudinal results of the national population health survey","volume":"17","author":"Reitsma","year":"2012","journal-title":"Pain Res Manag"},{"key":"B53","first-page":"53","article-title":"Chronic pain at ages 12 to 44","volume":"21","author":"Ramage-Morin","year":"2010","journal-title":"Health Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.24095\/hpcdp.31.4.04","article-title":"The prevalence of chronic pain and pain-related interference in the Canadian population from 1994 to 2008","volume":"31","author":"Reitsma","year":"2011","journal-title":"Chronic Dis Inj Can"},{"key":"B55","first-page":"15","article-title":"Chronic pain, activity restriction and flourishing mental health","volume":"26","author":"Gilmour","year":"2015","journal-title":"Health Rep"},{"key":"B56","first-page":"37","article-title":"Chronic pain in Canadian seniors","volume":"19","author":"Ramage-Morin","year":"2008","journal-title":"Health Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/j.pain.0000000000000776","article-title":"Health utilities in people with chronic pain using a population-level survey and linked health care administrative data","volume":"158","author":"Hogan","year":"2017","journal-title":"Pain"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1097\/j.pain.0000000000000561","article-title":"Incremental health care costs for chronic pain in Ontario, Canada: a population-based matched cohort study of adolescents and adults using administrative data","volume":"157","author":"Hogan","year":"2016","journal-title":"Pain"},{"key":"B59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1472-6904-9-11","article-title":"Dispensed drugs and multiple medications in the Swedish population: an individual-based register study","volume":"9","author":"Hovstadius","year":"2009","journal-title":"BMC Clin Pharmacol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/pds.5321","article-title":"Assessing polypharmacy in the older population: comparison of a self-reported and prescription based method","volume":"12","author":"Van der Heyden","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B61","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1177\/0049124106292364","article-title":"Advances in group-based trajectory modeling and an sas procedure for estimating them","volume":"35","author":"Jones","year":"2007","journal-title":"Sociol Methods Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0049124101029003005","article-title":"A sas procedure based on mixture models for estimating developmental trajectories","volume":"29","author":"Jones","year":"2001","journal-title":"Sociol Methods Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1037\/1082-989X.4.2.139","article-title":"Analyzing developmental trajectories: a semiparametric, group-based approach","volume":"4","author":"Nagin","year":"1999","journal-title":"Psychosoc Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/2137284","article-title":"Revisiting the behavioral model and access to medical care: does it matter?","volume":"36","author":"Andersen","year":"1995","journal-title":"J Health Soc Behav"},{"key":"B66","doi-asserted-by":"publisher","first-page":"Doc11","DOI":"10.3205\/psm000089","article-title":"Re-revisiting Andersen\u2019s behavioral model of health services use: a systematic review of studies from 1998 to 2011","volume":"9","author":"Babitsch","year":"2012","journal-title":"Psychosoc Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e004264","DOI":"10.1161\/JAHA.116.004264","article-title":"Race-sex differences in statin use and low-density lipoprotein cholesterol control among people with diabetes mellitus in the reasons for geographic and racial differences in stroke study","volume":"6","author":"Gamboa","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B68","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/mlr.0000000000000905","article-title":"Validation of the combined comorbidity Index of charlson and elixhauser to predict 30-day mortality across Icd-9 and Icd-10","volume":"56","author":"Simard","year":"2018","journal-title":"Med Care"},{"key":"B69","article-title":"How to Integrate Sex and Gender into Research Ottawa: Canadian Institutes of Health Research","year":"2023"},{"key":"B70","doi-asserted-by":"publisher","first-page":"E1189","DOI":"10.1503\/cmaj.190085","article-title":"Testing group differences for confounder selection in nonrandomized studies: flawed practice","volume":"191","author":"Sourial","year":"2019","journal-title":"CMAJ"},{"key":"B71","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511974175","volume-title":"Multivariable Analysis: A Practical Guide for Clinicians and Public Health Researchers","author":"Katz","year":"2011"},{"key":"B72","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4172\/2161-1165.1000227","article-title":"Multicollinearity in regression analyses conducted in epidemiologic studies","volume":"6","author":"Vatcheva","year":"2016","journal-title":"Epidemiology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0304-3959(93)90167-n","article-title":"Polymedication and medication compliance in patients with chronic non-malignant pain","volume":"52","author":"Berndt","year":"1993","journal-title":"Pain"},{"key":"B74","first-page":"37","article-title":"Medication use among senior Canadians","volume":"20","author":"Ramage-Morin","year":"2009","journal-title":"Health Rep"},{"key":"B75","doi-asserted-by":"publisher","first-page":"686990","DOI":"10.3389\/fphar.2021.686990","article-title":"High prevalence of multimorbidity and polypharmacy in elderly patients with chronic pain receiving home care are associated with multiple medication-related problems","volume":"12","author":"Schneider","year":"2021","journal-title":"Front Pharmacol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e0168987","DOI":"10.1371\/journal.pone.0168987","article-title":"Chronic pain: how challenging are ddis in the analgesic treatment of inpatients with multiple chronic conditions?","volume":"12","author":"Siebenhuener","year":"2017","journal-title":"PLoS One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1586\/14737167.2013.851006","article-title":"Economic implications of potential drug-drug interactions in chronic pain patients","volume":"13","author":"Taylor","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1089\/jwh.2007.0731","article-title":"Gender and age differences in medications dispensed from a national chain drugstore","volume":"17","author":"Antony","year":"2008","journal-title":"J Womens Health"},{"key":"B79","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/jwh.2007.0422","article-title":"Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance","volume":"17","author":"Stock","year":"2008","journal-title":"J Womens Health"},{"key":"B80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/dhps.S67425","article-title":"Persistent nonmalignant pain management using nonsteroidal anti-inflammatory drugs in older patients and use of inappropriate adjuvant medications","volume":"7","author":"Rianon","year":"2015","journal-title":"Drug Healthc Patient Saf"},{"key":"B81","first-page":"1","article-title":"Prevalence of prescription pain medication use among adults: United States, 2015\u20132018","author":"Hales","year":"2020","journal-title":"NCHS Data Brief"},{"key":"B82","doi-asserted-by":"publisher","first-page":"643","DOI":"10.5414\/cpp45643","article-title":"Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992\u20132002","volume":"45","author":"Haider","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B83","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12877-022-03279-x","article-title":"Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis","volume":"22","author":"Delara","year":"2022","journal-title":"BMC Geriatr"},{"key":"B84","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/fampra\/17.3.261","article-title":"The development of polypharmacy. A longitudinal study","volume":"17","author":"Veehof","year":"2000","journal-title":"Fam Pract"},{"key":"B85","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","article-title":"Polypharmacy in elderly patients","volume":"5","author":"Hajjar","year":"2007","journal-title":"Am J Geriatr Pharmacother"},{"key":"B86","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.maturitas.2020.05.018","article-title":"The world health organization (who) approach to healthy ageing","volume":"139","author":"Rudnicka","year":"2020","journal-title":"Maturitas"},{"key":"B87","volume-title":"Cihr Institute of Aging Strategic Plan 2019\u20132021: Living Longer, Living Better","year":"2023"},{"key":"B88","volume-title":"Ageing and Health","year":"2023"},{"key":"B89","doi-asserted-by":"publisher","first-page":"204137","DOI":"10.1093\/ecam\/nen065","article-title":"An international comparison of attitudes toward traditional and modern medicine in a Chinese and an American clinic setting","volume":"2011","author":"Burke","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"15690","DOI":"10.3390\/ijerph192315690","article-title":"Historical aspects of herbal use and comparison of current regulations of herbal products between Mexico, Canada and the United States of America","volume":"19","author":"Rojas","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B91","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12875-016-0577-x","article-title":"Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Huiskes","year":"2017","journal-title":"BMC Fam Pract"},{"key":"B92","article-title":"An Action Plan for Pain in Canada","author":"Campbell","year":"2021"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2025.1512878\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:39:28Z","timestamp":1740119968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2025.1512878\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":92,"alternative-id":["10.3389\/fpain.2025.1512878"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2025.1512878","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"article-number":"1512878"}}